In contrast to FIT, methylated ITGA4 is derived from exfoliated cells, and DNA methylation signatures are considered to maintain during colorectal carcinogenesis from adenoma to cancer [52], which may help to explain the significantly higher sensitivity than FIT for AA and stage I patients. The gene discussed is ITGA4; the disease is adenoma.